Statistics from Altmetric.com
We read with interest the study conducted by Galloway and colleagues on the risk of skin and soft tissue infections (SSTI) and herpes zoster (HZ) in patients with rheumatoid arthritis (RA) treated with tumour necrosis factor (TNF) antagonists versus non-biologic disease-modifying antirheumatic drugs (nbDMARDs).1 This study highlights the occurrence of common infections, such as SSTI and more uncommon infections such as HZ, when TNF antagonists and nbDMARDs are used in patients with RA with several …
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.